OpenCharities

This text was generated using OCR and may contain errors. Check the original PDF to see the document submitted to the regulator. This document is also available as Markdown.

← Queenscourt Hospice

2025-03-31-accounts

( )ueenscou rt ~~

where life is for living

==> picture [565 x 556] intentionally omitted <==

----- Start of picture text -----
To 31 st March 2025
= = ,
y income — y Hours of care
y Generation 7 provided by fyi
. ChOvela on, ka : Queenscourt |
4 ‘ . ‘ \ 2\ ‘ss f- \ ~
F Yoo hip / \
Customers Geary te / vl \
served at — GEOIEDLECIS /
2,347 our retail fre SUPPOrLnE aay,
Patients shops ww SY _Queenscourt .
loved & ‘Y iy; ; \ Pe iy
ones By Ve s ip a =
Ine Te
Re TAY
TT
eH Sena ©Ompassionat os
he eens ~ tOnate care for over 30 years —
----- End of picture text -----

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31st March 2025

==> picture [478 x 570] intentionally omitted <==

----- Start of picture text -----
OOO
PAGE
Report of the Chair 2
Impact Statement 3-5
Report of the Trustees 6-16
Report of the Independent Auditors 17 - 19
Statement of Financial Activities
(Incorporating Income & Expenditure Account) 20 - 21
Balance Sheet 22 - 23
Cash Flow Statement 24
Notes to the Cash Flow Statement 25
Notes to the Financial Statements 26 - 46
- ~
4 _ \ ye
| Muses ueenscourt
Pa ey ce Hospice
----- End of picture text -----

7 7

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31[st] March 2025 (continued)

Chair’s Foreword

The past year has been the first as Co-Chair of the Queenscourt Council and the first in which I am writing opening words to this report. Whilst this report provides a historical account of the period from 1[st] April 2024 to 31[st] March 2025, it is also appropriate to highlight the key developments taking place as we prepare for Queenscourt’s 37[th] Annual General Meeting in October 2025.

Queenscourt Council of Trustees operates within the framework of law and practice established by several regulatory authorities, meaning that the Council is held to very high standards in the performance of its duties. The strategic direction and governance of Queenscourt is the responsibility of the Council of Trustees. This responsibility is complex and multi-faceted, requiring dedication, expertise, time and commitment.

Along with individual Trustee training and development, the overarching Council membership is kept under constant review in recognition of the demands of the role and the need for continuous refresh. Since the end of March 2024 we have welcomed 4 new trustees, each bringing new perspectives and skills that will benefit Queenscourt and the communities we serve. We remain ever grateful for the seemingly inexhaustible supply of people willing to give their time to act as our Trustees and a little more detail on our Trustee tenures and new appointments is available within the body of our Trustee report.

I wish to mention the forthcoming retirement of two Trustees who have each served the Queenscourt Council for a period of nine years. That retirement is a necessary step for our Council to demonstrate our commitment to recommended best practice and governance. There is only space here to mention their contributions briefly, and to truly acknowledge the immeasurable and invaluable contribution of Anthony Crewe and Geraldine Boocock would take some considerable time and several pages of print. To each of them we offer our heartfelt thanks and best wishes.

Over the past 18 months we have been embedding our Board Assurance Framework (BAF) to further evidence the assurance and accountability provided by our sub-committee structure. The reports provided by each sub- committee chair to the full council meetings and the new governance structure provided by the Board Assurance Framework allow Trustees to become more involved in every aspect of Queenscourt. It also facilitates engagement with the Directors and senior members of management in real time, ensuring the Trustees can offer in depth contribution to their respective sub-committees and enhancing our development in these particular focus areas.

The Impact Statement included in this report demonstrates the many ways in which we touch the lives of our local communities, whether that be through our clinical service delivery, our family and bereavement support or through other activities like our shops and fundraising events. Our Star Trekk walk broke records for participation again this year. It has certainly caught the imagination of our local communities and the businesses that support us through their participation and sponsorship.

I want to send thanks to all our local communities for supporting us, whether you do so with your time as a volunteer, or through some kind of financial contribution. Everything that you do to support us means that we can continue providing our services. Queenscourt services are varied, complex, specialist and vital and it requires significant expenditure just to maintain the status quo. We are grateful for every bit of the support you are able to give.

I must also highlight the dedication, focus and commitment of our three Directors Ms Debbie PierceLawson, Dr Clare Finnegan and Mrs Louise Charnock and the outstanding contribution that they have made in the last 12 months. We are indeed very fortunate to have them leading from the front in every respect.

Finally, I would like to thank all our staff, both clinical and non-clinical for everything they do. Along with our volunteers, our paid staff work incredibly hard to ensure we can continue offering the services and support that are so essential for people during some of the most difficult times in their lives.

Terry McGraw Co-Chair of Trustees

��

A 5VO2 TS i, i —_ t B Ee c ~ 5 : SH A | ; = 948 Patients Supported ff < by Queenscourt Services UNS - Queenscourt at F;lee @ \p Jie| 4A QueenscourtHours of care at providedHome by Our [npalienl Unit7 BR 91% % 3% 170 ’ |A) Ofpede CH} Of patients oe “«~a ChicanachintHomediedin at passionHome died inae QueenscourAdmitted t o's “their own home Queenscourt Hospice Inpatient Unit 1,638\ D) 2O7R 10.17 DAYS atinDay Shifts 2,301,Care shifts Night/729y Shiftsae. hsnaniees tanec eden provided by of those admitted to Queenscourt Queenscourt Hospice at Home Inpatient Unit

==> picture [573 x 815] intentionally omitted <==

----- Start of picture text -----
ae oo
y [CBs]
~ 2\ Average.ength o This year, we grew our
‘~f= Connect X(S sae209.49 Teeyr Tove!
iss ~ sa & Days
f . ty - ta a . .
¥ A - X & '
\wy (on |\37) mate |S SupportedPatients Keepinging ini Touch Team
¥ Be— : / » | Outpatient"
\F ys abs Therapy
‘
Palliatrve Care Services
—————ee—_
/ homePeople fromwerehospital supported on &6&
‘rapid end of life Patients seen in hospital
discharge’ 100% of those patients received
first contact within 2 days
GoldFrameworkStandard patients 1 8 296
died under care of Patients seen in the community
service ,
100% of those patients received
first contact within 3 days
\/
What : a ey (86 é
Our Patients & Families Said Inpatient Unit
NE ————— The staff at Queenscourt have
been amazing, nothing too much
. coupe.All <4 Dessert Ieee
oO iWa ntGreatCa re thereferred momentfrom| washospitaladmittedand itfrom has
1 6)O jf Transtorming Mealthcare beenarranged a wonderful an afternoon experience. IPU tea with ,
prosecco for i family, what a oe "
ORGANISATION ial treat. 1
‘6
POSITIVE een ae i) \
EXPERIENCE Queenscourt at Home d |
(On Average) Everyone who has helped our family ON
en has been friendly and kind. The =)
ke fk *** beeninforma ex t remelyion we h elpful, practicalave been given has and 1. & 1 5
gical No one has made us feel as if 4
they were in a hurry. We could not , ‘ “
have had better support. Each and \ Tr
every sister has been wonderful. = mm |
99 a
----- End of picture text -----

==> picture [586 x 765] intentionally omitted <==

----- Start of picture text -----
oo
e.
. kW Wek
Level 5 - 4
ae LAE? Outstanding }
(=+ J) Ss achieved for
Me fo mK. Heh the 2nd year gal
zef | V/ | aa runnin! ia ( Aang
q olunteers BRITAIN ane:
Supporting IN BLOOM? a.
| rs@ Queenscourt saa tn —
=] Z throughout the year = | \
Terence Burgess CLINICAL PLACEMENTS FOR
MACKAY MZ ATEDUCATION MEDICAL
SESSIONS STUDENTS
4 ddays
Lunch & Learn per year 376 1 22
Sessions provided Protected time for !NDIVIDUALS COMPLETED
for Corporate Staff Clinical Education Cane’sraNtinese TRAIN
f- | Communities 611
~ a rtunities= a Ea mnity SUnpate fers No ce
wi~Ww v ie ag 1,e74a] porrip e anioraeatoappariprovide ontacts @ Itwassuchandbacknice into to the beaast gesuable toevening,comefora
wn, @& Py | . isyear, said that they felt cared for,
Sah’ — »\_ wefurther invested into our puluenpealenacwaed
SOSA 6! F the best for them. It has
ae . yy) } ™ ~ Bereavement, Family made the arly want todo
ah Jej (\, Support & Carers Services eoscnetigtecrmed
Vitae / ° i | a ye Continuingour dedication to buildinga = hospice
MEAD. “4, ic Fos compassionate community... > and raise money 9
Pay \e People received Attended our
(A, tne a 698 Bereavement A38 Remembering
are: Support Evenings
Cl ierice.° > Introduction; so Research for
e ofour Patient eas use of Virtual
Innovation CX,S ToolDenendency patientseal wih
----- End of picture text -----

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31[st] March 2025 (continued)

1. What is Queenscourt and what do we do?

Queenscourt Hospice is an independent charitable organisation, and our purpose is to provide and promote the best possible consultant led, specialist palliative care for adults, within West Lancashire, Southport and Formby, who are clinically referred, with the agreement of their doctor and for whose clinical needs our services are appropriate. Our services are free of charge. All our charitable activities are undertaken to further our objectives for the public benefit.

We continually consider the new and innovative approaches that will best meet the needs of our local communities. Along with our clinical and medical colleagues, our service delivery is facilitated by a wide range of support from other vital members of #teamqueenscourt.

Hotel Services

All our catering is provided in-house. The catering team is particularly skilled at providing tiny, tasty, treats for those with poor appetites, liquidised and reformed food for those with swallowing difficulties and fortified food for those who struggle with volume. The catering team also provides subsidised meals for staff and our Terence Burgess Education Centre, TBEC.

We are able to provide a high-quality service responsive to individual patient needs in bright and pleasant surroundings, including beautiful gardens, thanks to our dedicated team of volunteer gardeners. Our housekeeping team keep Queenscourt clean, working with the clinical team to ensure Infection Prevention and Control Guidance is followed.

Corporate Services

All our patient-facing services are enabled and supported by our Corporate Teams, including Administration, Human Resources and Volunteering, I.T., Communications, Information Governance, Data, Finance, Health & Safety, Estates and Income Generation.

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31[st] March 2025 (continued)

2. #teamqueenscourt

Our staff and volunteers are our greatest asset. Most of our team are professionally qualified and many others are well qualified by the nature of their previous experience and the training that we provide. Our volunteer roles are many and varied. We have 423 active volunteers supporting us across all areas including clinical services, catering, the community, finance, fundraising and retail.

A large proportion of the patients we support have physically complex challenges and are psychologically distressed. Working as part of #teamqueenscourt, although immensely rewarding, can offer challenges. We offer a range of support to help with individual health and wellbeing, and a key strategic objective is to ensure that we are a compassionate employer. Specific initiatives during 2024/25 have included:

3. The future and Queenscourt Strategy[1]

As Trustees we oversee the ongoing development of our Strategic Direction. What we do now, and how we do it, will continue to be driven largely by factors that we can only hope to influence, rather than control. It is vital that we continue to engage in the regional and local landscapes of Integrated Commissioning Boards (ICB), Place Based Partnerships (PBP) and clinical networks.

Following the amendment to the Health and Care Act 2022 and the development of the PEOLC Commissioning Investment Framework that defines core/ specialist palliative care as the responsibility of the ICBs and / or Local Authority, there has been increased media awareness. There is also an increasing commitment from our 2 ICBs across Lancashire and South Cumbria and Cheshire and Merseyside to work with Hospice partners and identify a road map to a more sustainable funding settlement. So far, this commitment has been translated into the establishment of a commissioning review and a place-based needs assessment, both of which we are pleased to have full engagement. As a result of the commissioning review, we have also seen an increase in our recurrent funding contribution from Lancashire and South Cumbria ICB, which is indicative of the value placed on our services, particularly as the ICBs are experiencing significant financial challenges that mirror our own. A key objective for Queenscourt is to continue full engagement with the Hospice Collaboratives and ICBs to work toward a statutory funding contribution that at least matches the national average of 35%.

As a Council we continue to balance the need for investment in service development and the needs of our local communities with the responsibility to move toward a sustainable budget. We retain a significant level of reserves and are able to use these to achieve this balance in the short term. However, this position requires proper stewardship and an ability to accurately forecast our future financial health, allowing us to adjust our budget plans accordingly. Increasingly, we need assurance from statutory partners that the use of charitable reserves to balance our finances will reduce in line with a planned increase in their funding contributions. However, as yet there is no guarantee of further increases, and we continue to access charitable reserves to fund service delivery. As such, we have mechanisms in place that allow us to accurately forecast the impact of expected or sudden fluctuations in expenditure and income over the coming 3 years. Our Finance Committee uses this approach to support us in managing the significant financial risk we face, whilst still maintaining services and ensuring that we provide significant monetary contribution to the wider local health economy.

�������������������������������������������������������������

��

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31[st] March 2025 (continued)

Our Vision, Mission, Values & Objectives

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31[st] March 2025 (continued)

4. Where does our money come from?

We depend heavily upon the public within our community to provide the financial and practical support that we need to deliver the many services offered at Queenscourt. The main part of our income, whether in the form of donations or legacies, or by support for our shops, lottery and our other fundraising ventures, comes from members of the public, and we are eternally grateful to each and every one of them.

We continue to receive vital support, both financial and practical, from the NHS (funding 24% of our core costs) and we are most grateful to Mersey and West Lancashire Teaching Hospitals NHS Trust and to the two Integrated Care Boards (NHS Lancashire & South Cumbria and NHS Cheshire & Merseyside) that cover the areas we serve. We are particularly grateful for the significantly increased financial support received from NHS Lancashire and South Cumbria ICB. We continue to work closely with both ICBs in order to foster strong working relationships and ensure good communication. We will continue to provide support to our NHS colleagues during challenging financial times.

Furthermore, the Government has recognised that hospices nationally are under-funded and to this end they made some additional capital funding available to the hospice sector for the financial years 2024/25 and 2025/26. Queenscourt received £137,157 this year which was used to fund building improvements and new IT equipment that would otherwise have fallen to be met from revenue streams. A further £410,000 approximately will assist in our capital programme for 2025/26, but additional funding beyond that is as yet unknown.

Our lottery, shops, support groups and other trading activity generated £629,682 (£542,284 in 2023/24) whilst other donations and gifts (including gift aid) raised £1,394,499 (£1,298,691 in 2023/24). Net income from our lottery was substantially greater than last year (£248,271 compared to £174,314), after successfully outsourcing the operation of the lottery during the year. Our Retail portfolio has not performed so well this year but was still able to contribute £93,498 (compared to last year’s figure of £138,494).

Legacy income was only £196,724 in 2024/25 compared to £1,123,924 the previous year. This source of income is completely unpredictable but has usually provided a substantial contribution towards our costs. Without significant income from legacies, we may have difficulty sustaining services at existing levels.

5. How we carry out our fundraising

Queenscourt Hospice is a member of the Fundraising Regulator and as such, we adhere to the framework that we have created to ensure respectful, open, honest and accountable fundraising. All organisations listed on the register have shown commitment to good fundraising practice, and to following the Fundraising Regulator’s “Code of Fundraising Practice” and the “Fundraising Promise”. This information is clearly available on the Queenscourt website in the “Our Supporter Promise” section: - - https://www.queenscourt.org.uk/index.php/fundraising/our supporter promise.html

The Head of Income Generation and Communications is a member of The Chartered Institute of Fundraising and upholds the high standards of fundraising good practice and donor engagement that are inherent to Institute membership. Where Queenscourt works with third party organisations to fundraise for the charity, a “Commercial Participator’s Agreement” is put in place. The template used is the one recommended by the Institute of Fundraising and is a standard tripartite form of agreement between a charity, its trading company and a commercial participator.

In terms of working with a third-party marketing or fundraising company, Queenscourt ensures that all contracts state that the company complies with appropriate legislation and prevailing codes of practice, e.g. those issued by the Fundraiser Regulator for face-to-face, private site and street fundraising. Queenscourt also ensures that the companies adhere to regulations of relevant governing bodies

��

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31[st] March 2025 (continued)

including the Gambling Commission, Institute of Fundraising and the Fundraising Regulator, for example, around Problem Gamblers and Vulnerable People.

Income generation has been carried out by Queenscourt Hospice Retail Limited (our shops) and Queenscourt Hospice Enterprises Limited (our lottery, up to 19 July 2024 only), the financial details of which are shown in Note 4 to our accounts. This note includes £7,425 (2023/24 £6,103) raised by our official Supporter Groups, and Enterprises incurred £4,117 (2023/24 £46,083) on the use of an external telemarketing company who contact lapsed Lottery players about their membership.

The operation of our lottery was outsourced to a third-party lottery company for all draws after 19 July 2024. The transfer went smoothly with most of our lottery players choosing to continue supporting us this way. Queenscourt is one of a number of hospices throughout Great Britain supported by this company and between 60% and 80% of profits from individuals playing is donated Queenscourt Hospice.

The transition to a third-party Lottery Company has reduced overhead costs, and as a result of increasing the Lottery Membership to £5 per line to enter the Weekly Draw (from £4.34 per line under Queenscourt Lottery), this income area is now forecasting a significantly higher net return to Queenscourt moving forward.

The Lottery Company also commits to providing the same level of income that Queenscourt Lottery had at the point of transition, i.e. by maintaining the same amount of Lottery Entries that were in place at the point of transition. This will provide Queenscourt with a secure predictable income moving forward.

All working partnerships with third party agencies are monitored throughout the duration of the partnership, and are subject to change, or indeed termination, where deemed necessary, e.g. where there is a risk of actual harm to an individual working for or supporting the charity, or a risk of reputational damage to an individual or the charity.

Partnerships with third-party agencies are included on Queenscourt’s Asset Register, which is monitored and updated by the IT Manager who is also the Information Governance Officer. The Asset Register states who the main ‘Asset Owner’ is, i.e. who is primarily responsible for that partnership, what the purpose of it is, for example, Donor transactions, and what measures are in place to safeguard any information that is handled as a result of that activity, e.g. Donor data.

Queenscourt is fully committed to upholding the principles stated within the following directives: DPA - Compliant with Data Protection Act 2018 GDPR – General Data Protection Regulation (Regulation (EU) 2016/679)

To that effect, Queenscourt’s policy on handling data can be found on the website under the “Contact Preferences” section of “Our Supporter Promise”. The downloadable GDPR document also contains the relevant information on making a query about data processing, withdrawing consent, or initiating a complaint.

Queenscourt complies with the prevailing codes of practice issued by the Fundraising Regulator, - including the Fundraising Preference Service (FPS): www.fundraisingregulator.org.uk/fundraising preference-service The FPS is a free service, run by the Fundraising Regulator, that helps individuals to end contacts with charities they no longer want to hear from. It is the UK’s only official service that helps you manage the direct marketing contact that you receive from all registered charities in England, Wales and Northern Ireland. Queenscourt’s fundraising team receives a “Weekly Report” from the FPS to notify of anyone wishing to end contact with our charity.

���

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31[st] March 2025 (continued)

There were no complaints received in respect of fundraising during the past year, but a procedure is in place to ensure the timely investigation and resolution of complaints should they arise.

Queenscourt’s fundraising is PCI (Payment Card Industry) compliant, and the necessary attestation process is carried out on an annual basis. Queenscourt is registered with the Phone-paid Services Authority (PSA): www.psauthority.org.uk for any “Text To Donate” facility we use. This UK regulatory body is for individuals to check a phone number that they are unsure of on their phone bill.

We also adhere to appropriate internal policies to ensure that all income generation activity is conducted in a compliant fashion. Queenscourt policies relevant to fundraising include: Cash Handling Support Groups; Donors Charter; Corporate Partnerships, Cash & Banking, Money Laundering & Suspicious Transactions, Social Responsibility for Gambling, Security, Data, Problem Gamblers, Vulnerable People and Complaints Policy.

6 . Financial Review

The Charity is showing net expenditure in 2024/25 of £1,764,327 which compares to net expenditure of £541,048 the previous year, an increase of £1,223,279. The most significant factor contributing to this was legacy income which was down by £927,200, followed by staffing costs (which relate directly to the services we provide) increasing by £563,588, and a loss in value of investments of £277,677. Our financial position would have been somewhat worse had we not received an increase in funding from ICBs and NHS capital grant (a total of £434,418), and other increases in donations and fundraising income (£110,768).

Expenditure on the services the Hospice provides cost £14,903 per day compared to £13,630 the year before.

The charts below summarise our income sources and spending.

7 . Reserves and Investments

We have predicted further budget deficits for 2026/27 and future years. We work on three-year financial plans which seek to scale back our dependence on reserves and generate more income or savings on expenditure.

We have a number of designated funds which set aside money for specific purposes; these continuing to be a tangible fixed assets fund required for future depreciation charges, a budget deficit fund

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31[st] March 2025 (continued)

allocated to support a potential shortfall in the forthcoming year, a capital investment fund to support committed and planned enhancement of our assets, a contingency fund set aside in the event of nonrecurring expenditure requirements, the Dr Karen Groves legacy development fund specifically aimed at seeking donations to “Keep Queenscourt in Service” and Specialist Palliative Care Contracts fund to ensure that any surplus income arising on these contracts is re-invested in this part of the service. Our general (unrestricted) fund of £3,843,792 represents our free reserves, of which up to £1,535,000 may be attributed to being held as investment property rather than cash or other listed investments.

Our policy on reserves is to have a strong cash position to deal with unexpected costs and the occasional shortfall of income or difficulty with cash flow, so we aim to retain about £1.1m on short term deposit. To ensure the continuity of our services we also need a reserve to be sufficient to cover an extended operating deficit on core services for up to 2 years (i.e. current year and 12 months beyond) in order to allow time, if necessary, for us to re-organise our funding and operational strategies. At the time of setting our budget in March 2025 our forecast was for reserves to be adequate for more than 12 months beyond the 2025/26 financial year, assuming all income streams will be maintained.

We recognise that with inflation and modest interest rates, cash will lose its value. Nevertheless, we believe that it is sound policy to keep some short-term cash in CCLA’s Charities Deposit Fund. This paid an average of 4.78% during the year. However, we will consider other reputable deposit takers if better rates are available.

The Trustees have wide investment powers, and our other investments are principally in two areas: CCLA’s COIF Charities Investment Fund and the BlackRock Catholic Charities Growth and Income Fund. Both funds are invested mainly in equities and aim to at least maintain their real value and to yield a regular annual income. Income from our investments has yielded around £142,000 and whilst we continue to seek ways of improving our levels of income, we will not change our conservative view of risk in order to achieve this. We do not prescribe any requirements for socially responsible investments other than to avoid tobacco shares.

We also have investments in a property portfolio of 7 houses which are rented, two flats and a shop, which between them generated a net income of £73,000.

8. Our Constitution and Administrative Details

Queenscourt’s full name is Queenscourt Hospice. It is a Registered Charity, no. 518801, and a company limited by guarantee, registered in England No. 02102320 and incorporated in 1987. Its registered office is at Town Lane, Southport, PR8 6RE. It is not normally liable to taxation.

Queenscourt Hospice has two wholly owned subsidiaries:

Both companies exist to pay over all their available surpluses to Queenscourt Hospice.

���

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31[st] March 2025 (continued)

The Council

The members of the Council are the trustees of the charity and directors of the company. The following are trustees at the date of this report. They all served throughout the year, unless highlighted with commentary.

Rev. M Abrams Ms C Bernard (Co-Chair) Dr G Boocock Ms Valaina Bowker (from 11[th] Dec 2024) Ms J Campbell Ms G Causer Mr A Crewe (Co-Chair) Ms Y Burns (resigned 16[th] April 2024) Mr P Cutner (Treasurer)

Dr S Gardner (from 17[th] of June 2024) Ms L Hooton Mrs R Ingham (from 17[th] June 2024) Mr D Kemp Ms Hilary McLaren (from 17[th] of June 2024) Mr T McGraw (Co-Chair) Mr K B Wallis Ms M Tarpey (resigned 17[th] July 2024) Mr A Appleton (resigned 3[rd] May 2024)

Executive Directors

Medical Director: Dr Clare Finnegan, MBChB, FRCP, Dip Ethics, PGCert Teaching and Learning in Clinical Practice. She is a Consultant in Palliative Medicine for Merseycare NHS Foundation Trust and Southport and Formby NHS Foundation Trust, and Honorary Clinical Lecturer University of Liverpool and Edge Hill University.

Director of Clinical Services: Mrs Louise Charnock, RGN, MSc Advanced Clinical Practice, PG Certificate in Teaching and Learning in Clinical Practice, BSc (Hons) Specialist Practitioner (District Nursing), BSc (Hons) Nursing and Health Studies, DipHE Nursing

Director of Corporate Services and Company Secretary: Miss Debra Jane Lawson Dip SW, Dip HE, PG Certificate in Human Resource Development.

Other details:

Auditors: MHA, Exchange Station, Tithebarn Street, Liverpool, L2 2QP

Bankers: National Westminster Bank Plc, 130 Lord Street, Southport, PR9 0AB Solicitors: Hodge Halsall LLP, 2 Liverpool Road, Ainsdale, PR8 3LX

Brabners Chaffe Street LLP, Horton House, Exchange Flags, Liverpool L2 3YL Investment CCLA Investment Management Limited. 80 Cheapside, London EC2V 6DZ Managers: BlackRock Investment Management (UK) Limited. 12 Throgmorton Avenue, London, EC2N 2DL

9. Our Governance and Administration

We are regulated by the Care Quality Commission whose reports are published and appear on our website. We were rated ‘Good’ in all areas when last inspected. We are measured against quality indicators for each of our contracts.

‘I want great care’, our survey tool and focussed discussions with patients, families help us to identify what is necessary to meet their needs. We monitor reviews and comments from our social media for more informal feedback. We also monitor evaluation materials from our Education Centre.

For staff and volunteers our anonymous feedback tool, ‘Thymometrics’ allows all staff to rate how it feels to be employed by Queenscourt and to give feedback anonymously to the senior team. We also have Freedom to Speak Up processes embedded and a Freedom to Speak Up Guardian in place.

Our governing documents are the Memorandum and Articles of Association which the Council keeps under regular review. As members of the Council, we are Trustees of the Charity and Directors of the Company. Responsibility for the management of Queenscourt is vested in the Council which meets six times a year. We have set up governance and administrative arrangements whereby the day to day running of the hospice is delegated as appropriate to the Executive Directors who in turn attend Council meetings and participate in the Council subcommittees to support assurance mechanisms.

���

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31[st] March 2025 (continued)

The Board Assurance Framework (BAF) and subcommittee structure facilitates a clear process of monitoring and assurance for the Council of Trustees, focussed on our strategic risks and measured against key performance indicators within our strategic matrix.

Our quality dashboard assists us in monitoring progress and internal scrutiny is the remit of Integrated Governance subcommittee, which includes outside professionals and two Trustees. The Visiting Group are part of our Integrated Governance subcommittee and make quarterly visits where they talk to patients, staff, volunteers, carers and families about all aspects of their experience and present an update report to the Integrated Governance subcommittee to aid triangulation of data.

A Finance subcommittee oversees the financial aspects of the charity, reviews investments and reserves and makes recommendations to the Council. Our Strategy and Succession subcommittee details our vision for at least 3 years at a time and our Business Plan is reviewed each year to ensure we have tangible goals to monitor. This subcommittee also considers future proofing and succession.

Our Information Governance subcommittee provides the Council of Trustees with assurance that adequate and appropriate information governance structures, processes and controls are in place which ensure that the organisation delivers quality care and services and provides a safe environment for patients, families and visitors to the Hospice.

The purpose of the Communications and Marketing subcommittee is to provide effective communications oversight for the Hospice. The Communications and Marketing Committee will regularly monitor, review and report to the Council on the communications plans and communications performance of the hospice.

Our Education subcommittee exists to provide effective oversight of education strategy and delivery and the development of compassionate communities. The Education Committee monitors, reviews and reports to the Council on the education strategy and performance of TBEC, our delivery partnerships and our internal education programmes.

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31[st] March 2025 (continued)

10. How we manage risk

The Risk & Health and Safety subcommittee oversees risk management, and we maintain a Risk Register and policies with defined review dates, to ensure that we keep all Queenscourt’s activities under review.

We review our Risk Management Strategy annually. The Risk & Health and Safety subcommittee oversees the strategic risk register, and each subcommittee has ownership of the specific strategic risks that Queenscourt faces. The subcommittees meet quarterly.

11. Members and the Election and Appraisal of Trustees

There are some 127 members of the Company who are former or current subscribers to Queenscourt’s funds. An important function of the members is to elect or re-elect Trustees, one third of whom retire each year at the Annual General Meeting. The Council can and does recommend candidates for election.

The Council’s policy is to appraise its performance as a Council, using a learning needs analysis and the production of the Council Development Plan. At least once every 3 years the effectiveness of the Council is also reviewed against benchmarks, including the Charity Governance Code.

The Co-Chairs and Trustees undertake peer reviews which inform the training and development activity that is programmed each year. We aim to maintain a good mix of skills on the Council and to give new members appropriate induction and instruction. Council subcommittees have delegated responsibility to oversee our financial performance and monitor our performance.

At the date of this report, we have 15 Trustees. The maximum tenure for Trustees under recommended practice is 9 years and we follow this recommended practice, only authorising longer periods of tenure under exceptional circumstances or to support succession as overseen by our Strategy and Succession committee.

At the 2025 AGM one of our Co-Chairs, Mr Anthony Crewe and Dr Geraldine Boocock will be retiring as members of the Council as they have reached the maximum tenure of 9 years. We would like to record our grateful thanks for the many years that they each gave in support of Queenscourt and for all their support, hard work and guidance during their time with us.

12. Statement of Trustees’ Responsibilities

The Trustees (who are also the Directors of Queenscourt Hospice for the purposes of company law) are responsible for preparing the Trustees’ Annual Report and the financial statements in accordance with applicable law and regulations. Company law requires the Trustees to prepare financial statements for each financial year. Under that law the Trustees have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law).

Under company law the Trustees must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the charitable Company and the income and expenditure of the charitable Company for that period.

In preparing these financial statements, the Trustees are required to:

���

Queenscourt Hospice (Registered number 02102320) Report of the Trustees for the year ended 31[st] March 2025 (continued)

The Trustees are responsible for keeping adequate accounting records that are sufficient to show and explain the charitable Company’s transactions and disclose with reasonable accuracy at any time the financial position of the charitable Company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the charitable Company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

In so far as the Trustees are aware:

13. Auditors

The auditor, MHA, previously traded through the legal entity MacIntyre Hudson LLP. In response to regulatory changes, MacIntyre Hudson LLP ceased to hold an audit registration with the engagement transitioning to MHA Audit Services LLP.

Following a competitive tender process in advance of the next year ended 31 March 2026, MHA will not be proposed for reappointment in accordance with section 485 of the Companies Act 2026.

By order of the Council

Terry McGraw Terry McGraw Co-Chair Co-Chair

September 16, 2025 Date:

Queenscourt Hospice (Registered number 02102320) Independent Auditors’ Report

Opinion

We have audited the financial statements of Queenscourt Hospice (the ‘parent charitable company’) and its subsidiaries (the ‘group’) for the year ended 31 March 2025 which comprise the Statement of Financial Activities (of both the group and the parent charitable company), the Balance Sheets (of both the group and the parent charitable company), the Group Cash Flow Statement and notes to the financial statements, including a summary of significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards (United Kingdom Generally Accepted Accounting Practice), including Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditors' responsibilities for the audit of the financial statements section of our report. We are independent of the group and parent charitable company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the trustees' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the group’s ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the trustees with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the Report of the Trustees, other than the financial statements and our Report of the Independent Auditors thereon. The Trustees are responsible for the other information contained within the Report of the Trustees. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon.

Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the audit or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

���

Queenscourt Hospice (Registered number 02102320) Independent Auditors’ Report

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of the audit:

• the Report of the Trustees has been prepared in accordance with applicable legal requirements. In the light of the knowledge and understanding of the group and parent charitable company and its environment obtained in the course of the audit, we have not identified material misstatements in the Report of the Trustees.

Matters on which we are required to report by exception

We have nothing to report in respect of the following matters where the Companies Act 2006 requires us to report to you if, in our opinion:

Responsibilities of the trustees

As explained more fully in the Statement of Trustees’ Responsibilities, the trustees (who are also the directors of the charitable company for the purposes of company law) are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the trustees determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the trustees are responsible for assessing the charitable company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the trustees either intend to liquidate the charitable company or to cease operations, or have no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud is detailed below:

���

Queenscourt Hospice (Registered number 02102320) Independent Auditors’ Report

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

A further description of our responsibilities for the audit of the financial statements is located on the Financial Reporting Council’s website at www.frc.org.uk/auditorsresponsibiIities. This description forms part of our Report of the Independent Auditors.

Use of our report

This report is made solely to the charitable company’s members, as a body, in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the charitable company’s members those matters we are required to state to them in an auditors' report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the charitable company and the charitable company's members as a body, for our audit work, for this report, or for the opinions we have formed.

Andrew Matthews BFP ACA FCCA

(Senior Statutory Auditor) For and on behalf of MHA, Statutory Auditor

Exchange Station Tithebarn Street Liverpool L2 2QP

September 16, 2025 Date: __

MHA is the trading name of MHA Audit Services LLP, a limited liability partnership in England and Wales (registered number OC455542)

Queenscourt Hospice (Registered company number 02102320)

Consolidated Statement of Financial Activities (Incorporating an Income and Expenditure Account) For the year ended 31 March 2025

GROUP
Note
Income and Endowments from
Donations and legacies
2
Charitable activities
3
Other trading activities
4
Investment income
5
Other Income – including Capital grants and
Insurance claims
6
Total income
Expenditure on
Raising funds
4
Charitable activities
7
Investment property management costs
Total expenditure
Net incoming / (outgoing) resources before
other gains and losses
Net gains/(losses) on investments
Net Income
8
Transfers between funds
18
Other recognised gains/(losses)
Net gains/(losses) on disposal of assets
Net movement in funds
Reconciliation of Funds
Total funds brought forward
Total Funds Carried Forward		 Unrestricted
funds
£
1,449,714
2,721,986
1,059,216
257,090
4,945
5,492,951
982,096
6,438,469
17,124
7,437,689
(1,944,738)
(18,821)
(1,963,559)
137,157
-
(1,826,402)
11,411,854
9,585,452		 Restricted
funds
£
141,509
-
-
-
137,157
278,666
-
93,600
-
93,600
185,066
-
185,066
(137,157)
-
47,909
390,898
438,807		 Total
2025
£
1,591,223
2,721,986
1,059,216
257,090
142,102
5,771,617
982,096
6,532,069
17,124
7,531,289
(1,759,672)
(18,821)
(1,778,493)
-
-
(1,778,493)
11,802,752
10,024,259		 Total
2024
£
2,422,615
2,430,856
1,093,430
280,368
1,795
6,229,064
1,026,746
5,972,650
29,161
7,028,557
(799,493)
258,856
(540,637)
-
-
(540,637)
12,343,389
11,802,752

Continuing operations

All income and expenditure has arisen from continuing activities.

A separate statement of financial activities for the Charity alone is shown with comparative figures for the previous year.

The notes form part of these financial statements.

���

Queenscourt Hospice (Registered company number 02102320)

Statement of Financial Activities (Incorporating an Income and Expenditure Account) For the year ended 31 March 2025

CHARITY
Note
Income and Endowments from
Donations and legacies
2
Charitable activities
3
Other trading activities
4
Investment income
5
Other Income – Capital grants
6
Total income
Expenditure on
Raising funds
4
Charitable activities
7
Investment property management costs
Total expenditure
Net incoming / (outgoing) resources
before other gains and losses
Net gains/(losses) on investments
Net Income
8
Transfers between funds
18
Other recognised gains/(losses)
Net gains/(losses) on disposal of assets
Net movement in funds
Reconciliation of Funds
Total funds brought forward
Total Funds Carried Forward		 Unrestricted
funds
£
1,449,714
2,721,986
629,682
255,195
-
5,056,577
531,556
6,438,469
17,124
6,987,149
(1,930,572)
(18,821)
(1,949,393)
137,157
-
(1,812,236)
11,396,248
9,584,012		 Restricted
funds
£
141,509
-
-
-
137,157
278,666
-
93,600
-
93,600
185,066
-
185,066
(137,157)
-
47,909
390,898
438,807		 Total
2025
£
1,591,223
2,721,986
629,682
255,195
137,157
5,335,243
531,556
6,532,069
17,124
7,080,749
(1,745,506)
(18,821)
(1,764,327)
-
(1,764,327)
11,787,146
10,022,819		 Total
2024
£
2,422,615
2,430,856
542,284
277,908
-
5,673,663
471,756
5,972,650
29,161
6,473,567
(799,904)
258,856
(541,048)
-
-
(541,048)
12,328,194
11,787,146

Continuing operations

All income and expenditure has arisen from continuing activities.

The notes form part of these financial statements.

���

Queenscourt Hospice (Registered company number 2102320)

Consolidated Balance Sheet As at 31 March 2025

Total Total
GROUP Notes 2025 2024
£ £
Fixed Assets
Tangible assets 11 3,130,889 3,112,958
Investments
Investments 12 4,053,921 5,242,742
Investment property 13 1,535,000 1,465,000
8,719,810 9,820,700
Current Assets
Stock 2,540 823
Debtors 14 1,029,098 1,321,461
Cash at bank and in hand 886,502 1,369,464
1,918,140 2,691,748
Creditors
Amounts falling due within one year 15 (613,691) (709,696)
Net Current Assets 1,304,449 1,982,052
Total assets less current liabilities 10,024,259 11,802,752
Net Assets 10,024,259 11,802,752
Funds 18
Unrestricted funds (Unallocated) 3,845,232 5,233,517
Designated funds 5,740,220 6,178,337
Restricted funds 438,807 390,898
Total Funds 10,024,259 11,802,752

The notes form part of these financial statements.

The financial statements were approved and authorised for issue by the Board of Trustees and signed on its behalf by:

T McGraw – Co-Chair T McGraw — Co-Chair C P Cutner - Treasurer C P Cutner - Treasurer

Date: September 12, 2025

Queenscourt Hospice (Registered number 02102320)

Balance Sheet As at 31 March 2025

Total Total
CHARITY Notes 2025 2024
£ £
Fixed Assets
Tangible assets 11 3,130,889 3,112,958
Investments
Investments 12 4,145,923 5,334,744
Investment property 13 1,535,000 1,465,000
8,811,812 9,912,702
Current Assets
Stock 1,465 -
Debtors 14 1,053,421 1,435,862
Cash at bank and in hand 744,398 1,049,915
1,799,284 2,485,777
Creditors
Amounts falling due within one year 15 (588,277) (611,333)
Net Current Assets 1,211,007 1,874,444
Total assets less current liabilities 10,022,819 11,787,146
Net Assets 10,022,819 11,787,146
Funds 18
Unrestricted funds (Unallocated) 3,843,792 5,217,911
Designated funds 5,740,220 6,178,337
Restricted funds 438,807 390,898
Total Funds 10,022,819 11,787,146

The notes form part of these financial statements.

The financial statements were approved and authorised for issue by the Board of Trustees and were signed on its behalf by:

T McGraw – Co-Chair T McGraw — Co-Chail C P Cutner - Treasurer C P Cutner - Treasurer

Date: September 12, 2025

Queenscourt Hospice (Registered number 02102320) Consolidated Cash Flow Statement For the year ended 31 March 2025

GROUP
Notes
Cash flows from operating activities:
Cash generated from operations
Net cash provided by (used in) operating activities
Cash flows from investing activities:
Purchase of tangible fixed assets
Receipts from sale of tangible fixed assets
Purchase of fixed asset investments
Sale of fixed asset investments
Increase / (Decrease) in cash and cash equivalents in the year		 Total
2025
£
(1,417,901)
(1,417,901)
(165,061)
-
-
1,100,000
(482,962)		 Total
2024
£
(1,188,858)
(1,188,858)
-
-
(500,000)
1,600,000
(88,858)

���

Queenscourt Hospice (Registered number 02102320) Notes to the Cash Flow Statements For the year ended 31 March 2025

2025 2024
£ £
Net income/(expenditure) for the reporting period (as per the (1,759,672) (799,493)
statement of financial activities)
Adjustments for:
Depreciation charges 147,129 137,901
(Increase)/Decrease in debtors 292,364 (90,446)
(Increase)/ Decrease in stock (1,717) 504
Increase / (Decrease) in creditors (96,005) (437,324)
Net cash provided by (used in) operating activities (1,417,901) (1,188,858)
2.
Reconciliation of net cash flow to movement in net funds
2025 2024
£ £
Cash outflow / (inflow) (482,962) (88,858)
Movement in net funds (482,962) (88,858)
Net funds at 1 April 2024 1,369,464 1,458,322
Net funds at 31 March 2025 886,502 1,369,464
3.
Analysis of net funds
At 1 April Cashflow At 31
2024 March
2025
£ £ £
Cash at bank and in hand 1,369,464 (482,962) 886,502
1,369,464 (482,962) 886,502

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

1 Accounting policies

Basis of preparing the financial statements

The financial statements of the group and parent charitable company, which is a public benefit entity under FRS 102, have been prepared in accordance with the Charities SORP (FRS 102) 'Accounting and Reporting by Charities: Statement of Recommended Practice applicable to charities preparing their accounts in accordance with the Financial Reporting Standard applicable in the UK and Republic of Ireland (FRS 102) (effective 1 October 2019)', Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006. The financial statements have been prepared under the historical cost convention with the exception of investments which are included at market value. The financial statements are presented in sterling which is the functional currency of the charity.

The statement of financial activities (SOFA) and balance sheet consolidate the financial statements of the Charity and its subsidiary undertakings. The results of the subsidiary undertakings are consolidated on a line by line basis.

The Charity is a company limited by guarantee. The members of the company include the trustees named in the report of the trustees. In the event of the Charity being wound up, the liability in respect of the guarantee is limited to £1 per member of the Charity.

The parent charitable company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities and financial position and profit or loss of the group. The parent charitable company has therefore taken advantage of exemptions from the following disclosure requirements for parent company information presented within the consolidated financial statements.

Basis of consolidation

The consolidated group financial statements consist of the financial statements of the parent charitable company Queenscourt Hospice together with entities controlled by the parent (its subsidiaries).

All financial statements are made up to 31 March 2025. Where necessary adjustments are made to the financial statements of subsidiaries to bring the accounting policies used into line with those used by other members of the group.

All intra-group transactions, balances and unrealised gains on transactions between group companies are eliminated on consolidation. Unrealised losses are also eliminated unless then transactions provide evidence of an impairment to the asset transferred.

Income

All income is recognised in the Statement of Financial Activities once the charity has entitlement to the funds, it is probable that the income will be received and the amount can be measured reliably. Legacies and grants are recognised in the Statement of Financial Activities when they become receivable and it is reasonably certain that they will be received and can be measured

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

1 Accounting policies (continued)

with sufficient reliability. Income tax is recoverable monthly on completion of the documentation. Income is deferred only when the Charity has to fulfil conditions before becoming entitled to it. Gifts in kind are included at valuation, with the exception of food where the total involved is not material. Goods donated for resale are included as income when sold. No amounts are included in the financial statements for services donated by volunteers.

Expenditure

Liabilities are recognised as expenditure as soon as there is a legal or constructive obligation committing the charity to that expenditure, it is probable that a transfer of economic benefits will be required in settlement and the amount of the obligation can be measured reliably. Expenditure is accounted for on an accruals basis and has been classified under headings that aggregate all cost related to the category. Where costs cannot be directly attributed to particular headings they have been allocated to activities on a basis consistent with the use of resources.

The expenses of operating the Charity shops including depreciation of fixed assets employed in the shops relate entirely to fundraising. Also included in fundraising are separately identifiable expenses incurred at the main hospice building and in local support groups in connection with specific fundraising activities.

Tangible fixed assets

All assets costing more than £5,000 are capitalised. In addition, assets which qualify for capital grants but which cost less than £5,000 are also capitalised.

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Freehold Land: NIL Freehold Buildings: Between 2% and 4% per annum of cost Leasehold Improvements: 10% per annum of cost Equipment: Between 5% and 50% per annum of cost Fixtures and Fittings: Between 4% and 20% per annum of cost Motor Vehicles: Between 17% and 20% per annum of cost

Investments

Fixed asset investments and shares are included at market value at the balance sheet date.

Investment property is shown at most recent valuation.

The Statement of Financial Activities includes the net gains and losses arising on revaluations and disposals throughout the year.

Debtors

Trade and other debtors are recognised at the settlement amount due after any trade discount offered. Prepayments are valued at the amount prepaid net of any trade discounts due.

Creditors

Creditors are recognised where the charity has a present obligation resulting from a past event that will probably result in the transfer of funds to a third party and the amount due to settle the obligation can be measured reliably. Creditors are normally recognised at their settlement amount after allowing for any trade discounts due.

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

1 Accounting policies (continued)

Financial instruments

The Group only has financial assets and financial liabilities of a kind that qualify as basic financial instruments. Basic financial instruments are initially recognised at transaction value and subsequently measured at their settlement value.

Fund accounting

Unrestricted funds can be used in accordance with the charitable objectives at the discretion of the trustees.

Designated funds comprise unrestricted funds that have been set aside by the trustees for particular purposes. The aim and use of each designated fund is set out in the notes to the financial statements.

Restricted funds can only be used for particular restricted purposes within the objects of the charity. Restrictions arise when specified by the donor or when funds are raised for particular restricted purposes. Further explanation of the nature and purpose of each fund is included in the notes to the financial statements.

Pension costs and other post-retirement benefits

The Group contributed to the personal pension plans of 154 (2024: 142) of its employees. The pension cost charge represents contributions for the period payable to by the Group. Superannuation employers’ contributions are paid for employees remaining in the NHS pension scheme.

Operating leases

Rentals applicable to operating leases are charged to the SOFA on a straight line basis over the term of the lease.

Taxation

The Company is a registered charity and consequently there is no liability to taxation. The subsidiary companies are subject to UK Corporation Tax on profits not covenanted to the parent charity.

Government grants

Government grants are recognised at the fair value of the asset received or receivable when there is reasonable assurance that the grant conditions will be met and the grants will be received. A grant that specifies performance conditions is recognised in income when the performance conditions are met. Where a grant does not specify performance conditions it is recognised in income when the proceeds are received or receivable. A grant received before the recognition criteria are satisfied is recognised as a liability.

Judgements and key sources of estimation uncertainty

In the application of the Group’s accounting policies, the trustees are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods. The trustees believe that the following

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

1 Accounting policies (continued)

estimates and assumptions are significant in respect of the carrying amount of assets and liabilities:

Valuation of investment properties

Investment properties held by the group are reviewed annually by the trustees, utilising the advice from a local estate agent, but not a professional valuer. The trustees consider local market factors and rental yields when reviewing the fair value of investment properties, as well as the opinion of local estate agents. Given the uniqueness of the organisational property portfolio, the trustees appreciate the inherent difficulties and uncertainties around applying a fair value to the investment property portfolio, however, feel experienced enough to do this annually.

Recognition of legacy income

Throughout the year the trustees maintain a register of notifications of legacy income to be received, bequeathed by our valued donors. At each year end date, the trustees must provide for a figure of legacy income receivable, when its value and receipt is both measurable and probable. Whilst constrained by both the legal process and other market factors, such as property values, the trustees feel confident that their experience allows them to make accurate estimations and judgements around this future right to income in respect of legacies.

Going concern

The trustees assess whether the use of going concern is appropriate for the preparation of these accounts, i.e. whether there are any material uncertainties related to events or conditions that may cast significant doubt on the ability of the Group to continue as a going concern. The trustees make this assessment in respect of a period of at least one year from the date of authorisation for issue of the financial statements.

The trustees prepared a 3 year budget in April and also carried out an impact assessment in the event of budget plans falling short of expectations. These 3 year forecasts are also updated at each quarterly budget monitoring review by the finance committee.

As a consequence, the trustees have concluded that the Group has adequate resources to continue in operational existence for the foreseeable future and there are no material uncertainties about the Group’s ability to continue as a going concern, thus they continue to adopt the going concern basis of accounting in preparing the financial statements.

2 Donations and Legacies

GROUP AND CHARITY
Donations
Legacies
Remembrance gifts
Gift Aid
Regular and other donations including GAYE		 2025
£
305,840
196,724
166,545
109,650
812,464
1,591,223		 2024
£
345,650
1,123,924
173,903
114,160
664,978
2,422,615

Legacy income includes 2025 £nil restricted (2024: £1,107 restricted to funding Queenscourt at Home).

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

3 Income from charitable activities


Income from charitable activities
GROUP AND CHARITY
NHS Cheshire & Merseyside and Lancashire & South Cumbria ICBs
Other External Funding
Medical Income and Course Fees
Total		 2025
£
1,434,962
1,099,923
187,101
2,721,986		 2024
£
1,137,701
1,086,838
206,317
2,430,856

Income from the Integrated Care Boards includes £155,506 (2024: £124,371) Virtual Ward pilot (Lancs & S Cumbria). The balance of £1,279,456 (2024: £1,013,330) represents a contribution of around 24% (2024: 21%) to the core costs of the Hospice including Queenscourt at Home.

4 Other Trading Activities

Queenscourt Hospice Retail Limited, a wholly owned subsidiary company, manages the charity shops. The Charity owns the issued share capital of 92,000 fully paid shares of £1 each. (2024: 92,000 shares).

Queenscourt Hospice Enterprises Limited, a wholly owned subsidiary company, operated the lotteries until 19[th] July 2024. The company has now ceased trading but the Charity still owns the issued share capital of 2 fully paid shares of £1 each (2024: 2 shares)

An analysis of Group fundraising income and expenditure is shown below:

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

4 Other Trading Activities (continued)

Income
Covenant Income
Recharges to Subsidiary
Total Fundraising Income
Sundry income
Commission - gift-aided sales
Recharge to charity
Deposit Interest
Sub total
Fundraising Trading Costs
Recharges from Parent
Covenanted to Charity
Net Profit
Tax charge
Profit after Tax
Reserves as at 31 March
2025		 Retail
2025
£
488,184
-
-
488,184
3,805
1,140
112,554
1,628
607,311
(476,456)
(37,020)
(93,498)
337
-
337
1,440		 Lottery
2025 (in-
house)
£
130,041
-
-
130,041
-
-
-
267
130,308
(86,638)
(2,980)
(55,193)
(14,503)
-
(14,503)
-		 Lottery
2025
(external)
£
203,557
-
-
203,557
203,557
(10,479)
193,078
193,078		 Support
Groups and
other trading
2025
£
237,434
148,691
40,000
426,125
-
-
-
-
426,125
(521,077)
-
-
(94,952)
-
(94,952)		 Group
Total 2025
£
1,059,216
-
-
1,059,216
3,805
1,140
-
1,895
1,066,056
(982,096)
-
-
83,960
-
83,960		 Group
Total 2024
£
1,093,430
-
-
1,093,430
738
1,057
-
2,460
1,097,685
(1,026,746)
-
-
70,939
-
70,939

The Retail subsidiary has generated income of £28,186 (2024: £26,112) from gift aided donations.

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

5 Investment Income

GROUP
Interest income
Rents from investment property
CHARITY
Interest income
Rents from investment property
Other Income
GROUP
Commission on gift-aided sales (Unrestricted)
Sundry income (Unrestricted)
Insurance claims (Unrestricted)
DHSE Capital Grant (Restricted)
CHARITY
DHSE Capital Grant (Restricted)		 2025
£
167,185
89,905
257,090
165,290
89,905
255,195
2025
£
1,140
2,365
1,440
137,157
142,102
2025
£
137,157
137,157		 2024
£
192,423
87,945
280,368
189,963
87,945
277,908
2024
£
1,057
738
-
-
1,795
2024
£
-
-

6 Other Income

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

7 Costs of charitable activities

GROUP AND CHARITY

Direct costs
Staff costs
Payroll expenses and
training
Repairs and maintenance
Utilities and other
premises costs
Nursing, therapy &
education supplies
Catering supplies
Cleaning, laundry and
waste disposal
Transport and travel
General office expenses
Other operating expenses
Auditors’ remuneration
Bank charges
Other professional fees
Contract management
Depreciation
Support costs
reallocated
Allocation of support
costs
Human Resources
Communications
Data
Estates
Finance
Housekeeping
IT/IG
Volunteering
Corporate other
Depreciation
Other staff-related
Other premises related
Total
reallocated
to
above table		 Inpati
ent
Servic
es
£
1,326,
053
3,990
8,589
1,785
20,566
143
1,730
277
1,517
11,519
-
-
912
-
-
1,377,
081
453,08
3
1,830,
164
Inpatient
Services
£
44,950
19,493
17,641
102,849
63,842
49,657
21,455
10,428
23,125
74,558
25,085
-		 Queens
-court
at Home
£
554,860
274
662
-
232
-
-
16,111
3,572
1,163
-
-
1,047
-
-
577,921
117,230
695,151


Queens
-court
at Home

£

18,808

8,156

7,382

10,997

26,714

5,310

8,977

4,363

9,676

6,351

10,496

-

117,230		 Queens
-court
at Home
£
554,860
274
662
-
232
-
-
16,111
3,572
1,163
-
-
1,047
-
-
577,921
117,230
695,151


Queens
-court
at Home

£

18,808

8,156

7,382

10,997

26,714

5,310

8,977

4,363

9,676

6,351

10,496

-

117,230		 Other
Clinical
Services
£
1,045,179
5,224
3,873
1,274
772
43,565
1,262
8,204
12,907
8,272
-
-
2,022
-
-
1,132,554
312,152
1,444,706


Other
Clinical
Services

£

35,429

15,364

13,904

65,040

50,320

31,402

16,911

8,219

18,227

37,564

19,722

-

312,152		 Other
Clinical
Services
£
1,045,179
5,224
3,873
1,274
772
43,565
1,262
8,204
12,907
8,272
-
-
2,022
-
-
1,132,554
312,152
1,444,706


Other
Clinical
Services

£

35,429

15,364

13,904

65,040

50,320

31,402

16,911

8,219

18,227

37,564

19,722

-

312,152		 Education
£
403,180
3,181
4,898
-
4,176
822
-
941
8,407
1,093
-
-
361
-
-
427,059
137,494
579,915



Education

£

13,667

5,927

5,364

46,380

19,411

22,393

6,523

3,171

7,031

-

7,627

-

137,494		 Education
£
403,180
3,181
4,898
-
4,176
822
-
941
8,407
1,093
-
-
361
-
-
427,059
137,494
579,915



Education

£

13,667

5,927

5,364

46,380

19,411

22,393

6,523

3,171

7,031

-

7,627

-

137,494		 Medical
Services
£
739,993
2,983
175
-
-
-
-
13
1,910
776
-
-
121
-
-
745,971
143,692
889,663
Medical
Services
£
25,083
10,877
9,844
2,880
35,627
1,391
11,973
5,820
12,906
13,294
13,997
-		 Contracted
community
services
£
994,228
894
3,159
-
424
-
-
12,236
4,140
2,483
-
-
962
73,944
-
1,092,470
-
1,092,470


Contracted
community
services

£












 Contracted
community
services
£
994,228
894
3,159
-
424
-
-
12,236
4,140
2,483
-
-
962
73,944
-
1,092,470
-
1,092,470


Contracted
community
services

£












 Support
Services
£
782,410
22,527
48,305
91,393
-
-
29,489
760
51,133
49,041
16,350
3,265
11,155
(73,944)
131,767
1,163,651
(1,163,651)
-
Corporate
and Other
Costs
£
137,937
59,817
54,135
228,146
195,914
110,153
65,839
32,001
70,965
131,767
76,977
1,163,651		 2025
Total
activities
£
5,845,903
39,073
69,661
94,452
26,170
44,530
32,481
38,542
83,586
74,347
16,350
3,265
16,580
-
147,129
6,532,069
-
6,532,069
Method of
allocation
Staff costs
Staff costs
Staff costs
Floor area
Staff costs
Floor area
Staff costs
Staff costs
Staff costs
Floor area
Staff costs
Floor area		 2024
Restated
Total
activities
£
5,172,096
30,237
230,588
78,627
31,484
38,329
36,019
41,128
74,261
75,117
9,513
3,270
14,080
-
137,901
5,972,650
-
5,972,650















































































453,083 117,230 312,152 137,494 143,692

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

Governance costs

The following costs in respect of the Governance of the Charity are included in the preceding tables:

2025 2024
£ £
Auditors' remuneration for audit of the accounts 16,350 9,513
Auditors' remuneration for non-audit work - -
Staffing 216,110 176,800
Vantage IT system 5,245 5,000
__ __
237,705 191,313

8 Net income/(expenditure)

GROUP

Net income/(expenditure) is stated after charging/(crediting):

ROUP
et income/(expenditure) is stated after charging/(crediting):
2025 2024
£ £
Auditors' remuneration 20,384 14,508
Auditors' remuneration for non-audit work - 912
Depreciation - owned assets 147,129 137,901
Rentals – operating lease – Property 110,685 107,994
Rentals - operating lease - Equipment 8,757 5,637

CHARITY

Net income/(expenditure) is stated after charging/(crediting):

Auditors' remuneration
Auditors' remuneration for non-audit work
Depreciation - owned assets
Rentals – operating lease – Property
Rentals - operating lease		 2025
2024
£
£
16,350
9,513
-
-
147,129
137,901
110,685
107,994
8,757
5,637

9 Trustee’s renumeration and benefits

There were no trustees renumeration or other benefits for the year ended 31 March 2025 nor for the year ended 31 March 2024.

Trustees' expenses

No Council members received re-imbursed expenses (2024: £nil).

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

10
Staff costs
GROUP
Wages and salaries
Social security costs
Other pension costs
CHARITY
Wages and salaries
Social security costs
Other pension costs		 2025
£
5,425,348
538,860
465,310
6,429,518
2025
£
5,153,746
521,041
458,671
6,133,458		 2024
£
4,815,963
473,833
401,005
5,690,801
2024
£
4,577,126
458,074
396,528
5,431,728

The average monthly number of employees during the year was as follows:

GROUP
Medical
Nursing
Therapists
Catering
Housekeeping
Fundraising & administration
Education
Maintenance
Retail
Lottery		 Full time
4
29
3
1
1
10
4
2
5
-
59		 Part time
5
45
2
6
4
26
3
-
8
0
99		 Bank
-
12
-
1
-
3
1
-
3
1
21		 Total 2025
9
86
5
7
5
39
8
2
16
1
179		 Total 2024
7
78
5
6
6
39
10
2
13
3
169

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

CHARITY
Medical
Nursing
Therapists
Catering
Housekeeping
Fundraising & Administration
Education
Maintenance		 Full time
4
29
3
1
1
10
4
2
54		 Part time
5
45
2
6
4
26
3
-
91		 Bank
-
12
-
1
-
3
1
-
17		 Total 2025
9
86
5
8
5
39
8
2
162		 Total 2024
7
78
5
6
6
39
10
2
153

Staff numbers exclude 14 (2024: 14) Council members, who are all non-executive Directors of the organisation.

The number of employees whose employee benefits (excluding employer pension costs) exceeded £60,000 was:


60,000 was:
2025 2024
£60,000 - £70,000 9 11
£70,001 - £80,000 2 1
£80,001 - £90,000 2 2
£90,001 - £100,000 1 -
£100,001 - £110,000 - -
£110,001 - £120,000 - 1
£120,001 - £130,000 3 2
£130,001 - £140,000 1 1

The key management personnel comprise of the 3 Executive Directors being the Medical Director, the Director of Nursing Services and the Corporate Services Director with total employee benefit costs of £241,013 (2024: £216,280).

In addition, a great amount of time, the value of which is impossible to reflect in these financial statements, is donated by volunteers.

Along with a standard defined contribution scheme, the company operates an exempt approved defined benefit scheme, namely the National Health Superannuation Scheme. The assets of this scheme are held separately and contributions to the scheme are charged to the statement of financial activities so as to spread the cost of pensions over employees’ working lives with the company. This scheme does not have a real pension fund, but as a statutory scheme, benefits are fully guaranteed by the Government. Contributions from both members and employers are paid to the Exchequer, which meet the cost of increasing benefits each year by the rate of inflation. This extra cost is not met by contributions from scheme members and employers, as a result of the nature of the scheme there are no separately identifiable assets and liabilities which can be identified as relating to Queenscourt Hospice therefore, as permitted by FRS102, the scheme has been accounted for as a defined contribution scheme.

The contributions to the superannuation scheme were substantially defrayed by the Integrated Care Boards (formerly Clinical Commissioning Groups).

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

11
Tangible fixed assets
GROUP
Cost
At 1 April 2024
Additions
Disposals
At 31 March 2025
Depreciation
At 1 April 2024
Charge for year
Eliminated on disposal
At 31 March 2025
Net book value
At 31 March 2025
At 31 March 2024		 Freehold
property
£
4,154,739
59,372		 Fixtures &
fittings
£
838,287
44,222		 Equipment
£
319,410
61,467		 Totals
£
5,312,436
165,061
4,214,111
1,389,973
93,715		 882,509
564,567
35,891		 380,877
244,939
17,523		 5,477,497
2,199,479
147,129
1,483,688
2,730,423
2,764,766		 600,458
282,051
273,720		 262,462
118,415
74,471		 2,346,608
3,130,889
3,112,957

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

11
Tangible fixed assets (continued)
CHARITY
Freehold
property
£
Cost
At 1 April 2024
4,150,529
Additions
59,372
Disposals
-
At 31 March 2025
4,209,901
Depreciation
At 1 April 2024
1,385,763
Charge for year
93,715
Eliminated on disposal
-
At 31 March 2025
1,479,478
Net book value
At 31 March 2025
2,730,423
At 31 March 2024
2,764,766		 11
Tangible fixed assets (continued)
CHARITY
Freehold
property
£
Cost
At 1 April 2024
4,150,529
Additions
59,372
Disposals
-
At 31 March 2025
4,209,901
Depreciation
At 1 April 2024
1,385,763
Charge for year
93,715
Eliminated on disposal
-
At 31 March 2025
1,479,478
Net book value
At 31 March 2025
2,730,423
At 31 March 2024
2,764,766		 Fixtures &
fittings
£
838,287
44,222
-		 Equipment
£
317,390
61,467
-		 Totals
£
5,306,206
165,061
-
4,209,901
1,385,763
93,715
-		 882,509
564,567
35,891
-		 378,857
242,919
17,523
-		 5,471,267
2,193,249
147,129
-
1,479,478
2,730,423
2,764,766		 600,458
282,051
273,720		 260,442
118,415
74,471		 2,340,378
3,130,889
3,112,957

Included in cost or valuation of land and buildings is freehold land of £30,000.

All tangible fixed assets are used for direct charitable purposes except for shop equipment which have net book values of £nil (2024: £nil) and are used for fundraising purposes.

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

12
Fixed asset investments
GROUP
Market value
At 1 April 2024
Additions
Disposals
Revaluations
At 31 March 2025
Net book value
At 31 March 2025
At 31 March 2024
CHARITY
Market value
At 1 April 2024
Additions
Disposals
Revaluations
At 31 March 2025
Net book value
At 31 March 2025
At 31 March 2024		 Shares in
group
undertakings
£
-
-
-
-
-
-
-
Shares in
group
undertakings
£
92,002
-
-
-
92,002
92,002
92,002		 Listed
investments
£
5,242,742
-
(1,100,000)
(88,821)
4,053,921
4,053,921
5,242,742
Listed
investments
£
5,242,742
-
(1,100,000)
(88,821)
4,053,921
4,053,921
5,242,742		 Totals
£
5,242,742
-
(1,100,000)
(88,821)
4,053,921
4,053,921
5,242,742
Totals
£
5,334,744
-
(1,100,000)
(88,821)
4,145,923
4,145,923
5,334,744

There were no investment assets held outside the UK.

Subsidiaries

Details of the charity’s subsidiaries at 31 March 2025 are as follows:

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

Queenscourt Hospice Enterprises Limited has taken the exemption in Section 479A of the Companies Act 2006 (“the Act”) from the requirement in the Act for their individual accounts to be audited. The guarantee given by the company under Section 479A of the act is disclosed in note 19.

13
Investment Property
GROUP AND CHARITY
Market value
At 1 April 2024
Additions
Disposals
Revaluations
At 31 March 2025
Net book value
At 31 March 2025
At 31 March 2024		 Totals
£
1,465,000
-
-
70,000
1,535,000
1,535,000
1,465,000

14 Debtors: Amounts falling due within one year

GROUP
Trade and other debtors
Prepayments and accrued income
Income tax recoverable
VAT reclaim
CHARITY
Amounts owed by group undertakings
Trade debtors
Prepayments and accrued income
Income tax recoverable
VAT reclaim		 2025
£
42,273
936,843
20,320
29,662
1,029,098
2025
£
52,466
42,273
908,700
20,320
29,662
1,053,421		 2024
£
5,456
1,282,323
11,076
22,606
1,321,461
2024
£
142,495
5,456
1,254,229
11,076
22,606
1,435,862

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

15 Creditors: Amount falling due within one year

GROUP
Trade and other creditors
Accruals and deferred income
CHARITY
Trade and other creditors
Accruals and deferred income		 2025
£
275,160
338,531
613,691
2025
£
249,746
338,531
588,277		 2024
£
264,548
445,148
709,696
2024
£
223,958
387,375
611,333

16 Leasing agreements

Lessee

Minimum lease payments under non-cancellable operating leases fall due as follows:

GROUP/ CHARITY
Expiring:
Within one year
Between two and five years
More than five years		 Land
2025
£
92,760
213,100
-		 & Buildings
2024
£
78,283
192,000
-
270,323		 Other operating leases
2025
2024
£
£
4,864
4,864
11,000
15,747
-
-
15,864
20,611		 Other operating leases
2025
2024
£
£
4,864
4,864
11,000
15,747
-
-
15,864
20,611
305,860 15,864 20,611

Lessor

The operating leases represent leases of properties to third parties. These leases are negotiated over terms between 6 months and 1 year. There are options for both parties to extend the lease terms.

At the reporting end date the charity had contracted with tenants for the following minimum lease payments:

GROUP
Expiring:
Within one year		 2025
£
6,815
6,815		 2024
£
6,735
6,735

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

17 Analysis of net assets between funds

GROUP
Unrestricted
funds
£
Fixed assets
3,130,889
Investments
5,588,921
Current assets
1,479,333
Current liabilities
(613,691)
9,585,452
CHARITY
Unrestricted
funds
£
Fixed assets
3,130,889
Investments
5,680,923
Current assets
1,360,477
Current liabilities
(588,277)
9,584,012		 GROUP
Unrestricted
funds
£
Fixed assets
3,130,889
Investments
5,588,921
Current assets
1,479,333
Current liabilities
(613,691)
9,585,452
CHARITY
Unrestricted
funds
£
Fixed assets
3,130,889
Investments
5,680,923
Current assets
1,360,477
Current liabilities
(588,277)
9,584,012		 Restricted
funds
£
-
-
438,807
-
438,807
Restricted
funds
£
-
-
438,807
-
438,807		 2025 Total
funds
£
3,130,889
5,588,921
1,918,140
(613,691)		 2024 Total
funds
£
3,112,958
6,707,742
2,691,748
(709,696)
10,024,259
2025 Total
funds
£
3,130,889
5,680,923
1,799,284
(588,277)		 11,802,752
2024 Total
funds
£
3,112,958
6,799,744
2,485,777
(611,333)
9,584,012 10,022,819 11,787,146

18 Movement in funds

Designated Funds

Designated Funds represent a part of the Unrestricted Funds that have been set-aside by the Trustees for specific purposes, these being:

Tangible Fixed Assets This is required in order to fund future depreciation charges.

Budget Deficit

This is to provide cover for the forthcoming year’s forecast deficit with the exception of depreciation charges which are included within tangible fixed assets.

Capital Investment

This is to provide funds for both committed and planned capital investment with the exception of where the Charity are holding any restricted funds for this purpose.

The Dr Karen Groves This fund was launched 2023 with the objective of boosting support Legacy Development to keep Queenscourt in service. Contributions to the fund are for Fund general use and are not restricted.

Specialist Palliative Care Contracts

This fund has been set up so that any profits earned on these contracted services can be carried forward and applied to support expenditure or losses in future years and ensure that at no point will the Hospice be supporting the contracts from charitable funds.

Contingency

This comprises funds set aside in the event that any future organisational restructure may require non-recurring expenditure.

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

18
Movement in funds (continued)
CHARITY
Unrestricted funds
General fund
Designated Fund
-
Tangible Fixed Assets
-
Budget Deficit
-
Capital Investment
-
Dr Groves Development Fund
-
Specialist Palliative Care Contracts
-
Contingency
Restricted funds
Restricted funds
Total funds
GROUP
Unrestricted funds
General fund
Designated Fund
-
Tangible Fixed Assets
-
Budget Deficit
-
Capital Investment
-
Dr Groves Development Fund
-
Specialist Palliative Care Contracts
-
Contingency
Restricted funds
Restricted funds
Total funds		 At 1 April
2024
£
5,233,517
3,112,958
1,962,611
-
-
102,768
1,000,000		 Net
movement
in funds
£
(1,956,146)
-
-
-
6,753
-
-
(1,949,393)
185,066
(1,764,327)
Net
movement
in funds
£
(1,970,312)
-
-
-
6,753
-
-
(1,963,559)
185,066
(1,778,493)		 Transfers
between
funds
£
582,027
17,931
(463,501)
-
(6,753)
7,453
-		 At 31
March
2025
£
3,845,232
3,130,889
1,499,110
-
-
110,221
1,000,000
At 1 April
2024
£
5,217,911
3,112,958
1,962,611
-
-
102,768
1,000,000
11,411,854
390,898
11,802,752		 Transfers
between
funds
£
582,027
17,931
(463,501)
-
(6,753)
7,453
-
137,157
(137,157)
-		 At 31
March
2025
£
3,843,792
3,130,889
1,499,110
-
-
110,221
1,000,000
9,585,452
438,807
10,024,259
11,396,248
390,898
11,787,146		 137,157
(137,157)
-		 9,584,012
438,807
10,022,819

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

18 Movement in funds (continued)

Net movement in funds, included in the above are as follows:

GROUP
Unrestricted funds
Unrestricted funds
Restricted funds
Restricted funds
Total funds
CHARITY
Unrestricted funds
Unrestricted funds
Restricted funds
Restricted funds
Total funds		 Incoming
resources
£000
5,492,951
278,666
5,771,617
Incoming
resources
£
5,056,577
278,666
5,335,243		 Resources
expended
£’000
(7,437,689)
(93,600)
(7,531,289)
Resources
expended
£
(6,978,149)
(93,600)
(7,080,749)		 Gains and
losses
£’000
(18,821)
-
(18,821)
Gains and
losses
£
(18,821)
-
(18,821)		 Movement
in funds
£’000
(1,963,559)
185,066
(1,778,493)
movement
in funds
£
(1,949,393)
185,066
(1,764,327)

An analysis of Restricted Funds is shown below:

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

18 Movement in funds (continued)

Equipment
Others
Staff Benevolent Fund
Grounds, Furniture, Man Shed
Education Fund
Compassionate Communities
Training
Fixtures & Fittings
The Big Give Campaign 2023
The Big Give Campaign 2024
Capital grant
Bequest for purchase of a
property
for
Retail
or
for
generating rental income		 Opening
balance
£
10,303
11,637
37
672
30,781
12,300
6,287
73,881
-
-
245,000		 Income
£’000
12,627
13,325
-
5,500
-
-
-
-
110,057
137,157
-		 Capital
Expenditure
£’000
-
-
-
-
-
-
-
-
-
(137,157)
-
(137,157)		 Revenue
Expenditure
£’000
(8,710)
(10,758)
-
(4,301)
(3,061)
(12,300)
(1,937)
(52,503)
(30)
-		 Closing
balance
£’000
14,220
14,204
37
1,871
27,720
-
4,350
21,378
110,027
-
245,000
390,898 278,666 (93,600) 438,807

Equipment:

This fund relates to monies received for the purchase of equipment for all areas of the Hospice.

Others:

Other service funds represent monies received for the provision of specific Hospice services.

Staff Benevolent Fund:

This fund relates to donations given specifically of the benefit of staff.

Grounds, Furniture, Man Shed:

This fund relates to funds received for the purchase and maintenance of garden equipment/furniture for the Hospice.

Education Fund:

This fund is used to support staff in learning new skills, increase knowledge and skillsets to better meet the needs of the communities and the Hospice.

Compassionate Communities Training:

This fund relates to training and supporting Compassionate Community Connectors who support the wellbeing of their community through compassionate conversations and encouraging social connections.

Fixtures & Fittings:

This fund relates to monies received for the purchase of fixtures and fittings for the Hospice.

���

Queenscourt Hospice (Registered company number 02102320)

Notes to the Financial Statements For the year ended 31 March 2025

18 Movement in funds (continued)

The Big Give Campaign 2023

This relates to funds raised through the Big Give campaign 2023 for improvements for the comfort of patients and particularly for heating.

The Big Give Campaign 2024

This relates to funds raised through the Big Give campaign 2024 to enhance family support and bereavement services.

Capital grant

The DHSC Capital Grant Programme refers to funding provided by the Department of Health and Social Care (DHSC) for capital projects, particularly in the context of healthcare and social care.

Bequest for purchase of a property for Retail or for generating rental income:

This fund is specifically for the purchase of retail property with the object of reducing the amount spent on renting such property or the purchase of retail or residential property for the purposes of generating income.

19 Financial commitments, guarantees and contingent liabilities

The Charity has undertaken to repay any legitimate claims in respect of donated, unclaimed client monies/bequests of £7,887 (2024: £4,000).

In order for the subsidiary entity Queenscourt Hospice Enterprises Limited to take the audit exemption available in Section 479A of the Companies Act 2006, the charity has guaranteed all outstanding liabilities of the subsidiary at 31 March 2025, until those liabilities are satisfied in full.

20 Contingent assets

Within the year there were material contingent assets of £148,000 (2024: £76,000) in respect of legacies to which the charity has a future right to income, but which are contingent upon certain legal processes completing in a future period. As such, the probability and measurement of these legacies is not reliable enough to provide in full for these assets at this point in time.

21 Related party transactions

On consolidation all transactions and closing balances with wholly owned subsidiary entities are netted against each other. The Trustees review Related Parties on a regular basis and deem no further transactions in the period to require disclosure.

22 Donated goods

Queenscourt Hospice Retail Ltd acts as an agent in selling donated goods and charged commission of £728 (2024: £1,057) for these services.

23 Contribution towards drugs

NHS Cheshire & Merseyside Integrated Care Board contributed £38,441 (2024: £39,126) towards drugs supplied by Southport and Ormskirk NHS Trusts.

���

==> picture [551 x 786] intentionally omitted <==

----- Start of picture text -----
We couldn't| have cs
Fundraisinge e
4|
ignlignts Queenscourt partnered with
—f Local Hospice Lottery
1,250 Fag - A
attended : on He in July 2024 aN
our Star Trekk an . Ko, \a3
uy £109,038nightwalk-anewrecord! [gedMiFee§=¥é 9 gAySare: Hoot Ry
Ge eecce BBA teres 7 548
a. Christmas Challenge f : newlottery
\Y 148 44) 000 my2024
nN of our supporters took part in a -
_ individual challenge for “1
Queenscourt
—T 6
FRE Retail Supe 180,782
“ na —— == Items sold ero
"ee Queenscourt Retai
.w wee x EXTRA made ingiftaid donations 97,836 @
i ve ’ki | & 4153 new sign-ups! Soe
and volunteers!
Thankyou 233:
Registered Office: Queenscourt Hospice | Town Lane | Southport | PR8 6RE
Company Limited by guarantee and registered in England No. 02102320 | Registered Charity No. 518801
----- End of picture text -----